HealthExec March 4, 2025
Chad Van Alstin

A private equity firm is set to close a $10 billion Walgreens buyout, people familiar with the deal told the Wall Street Journal.

According to the report, the deal could be finalized before the end of the week, with terms involving Sycamore Partners taking ownership of the struggling pharmacy chain. Sycamore Partners is a New York-based firm whose portfolio includes Staples, Belk and Hot Topic.

Talks surrounding the pending buyout were first revealed in December 2024.

The details being ironed out involve Sycamore Partners paying between $11.30 and $11.40 per share for Walgreens, which...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

Continue Reading

 
Topics: Investments, Mergers & Acquisitions / JV, Pharma, Pharma / Biotech, Trends
Related Articles:
Podcast: Jihye Han Compares First-In-Class Drug Regulation in the US and Europe
Enhancing primary care: The impact of pharmacist-led chronic care and AI-driven telehealth
Why Walgreens Specialty Pharmacy May Be Its Most Desirable Asset
Pharma Pulse 3/3/25: Will Tariffs Affect Branded Drug Prices? Pharmacists' Role in Medical Cannabis Counseling and Patient Education & more
Pharma’s Role in Ensuring Patient Access to Trustworthy Health Insights

Share This Article